查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869864

血流動力學監測設備市場規模、佔有率和趨勢分析報告：按系統類型、產品、最終用途、地區和細分市場預測（2025-2033 年）

Hemodynamic Monitoring Devices Market Size, Share & Trends Analysis Report By System Type (Invasive, Minimally Invasive, Non-Invasive), By Product (Disposables, Monitors), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

血流動力學監測設備市場摘要

2024年全球血流動力學監測設備市場規模估計為15.8億美元，預計2033年將達到27.8億美元。

預計從 2025 年到 2033 年，該行業將以 6.5% 的複合年成長率成長。這一成長是由幾個關鍵因素驅動的，包括心血管疾病和嚴重疾病的患病率上升、人工智慧和預測分析的融合、對微創和非侵入性監測技術的需求不斷成長，以及監測設備的技術進步，包括即時數據和無線連接。

心血管疾病（CVD）及其相關危險因子的增加預計將推動對血流動力學監測設備的需求。血流動力學監測設備在評估和降低心臟衰竭風險方面發揮日益重要的作用。血流動力學監測設備，例如植入式設備，可提供肺動脈壓力等因素的客觀數據，使醫生能夠識別因心臟衰竭而住院或死亡風險較高的患者。心臟衰竭是全球主要死因之一。例如，根據美國疾病管制與預防中心（CDC）的數據，美國約有670萬20歲及以上的成年人患有心臟衰竭。

此外，心臟麻痹（SCA）發生率的不斷上升也持續推動對血流動力學監測設備的需求。心臟麻痹通常病情嚴重甚至致命，在許多國家，尤其是院外發生的心臟驟停，存活率都很低。根據美國心臟協會（AHA）發布的《2022年心臟和中風統計數據》，美國每年發生超過35.6萬例院外心臟麻痹，其中約90%導致死亡。因此，心臟麻痹的持續增加預計將導致心臟心律調節器的需求增加。

對於老年加護病房（ICU）患者而言，謹慎的血流動力學管理至關重要，因為心血管系統會隨著老齡化成長而顯著變化。隨著年齡成長，自主神經系統的平衡逐漸改變，靜息狀態下副交感神經活動減弱，交感神經活動增強。這種失衡會增加老年人發生心血管併發症的風險。

與此同時，世界人口正在迅速老化。根據世界衛生組織估計，60歲及以上人口數量預計將從2020年的約10億增加到2030年的14億，到2050年將達到約21億。因此，近年來老年嚴重症患者數量顯著增加，凸顯了對這一脆弱人群進行先進血流動力學監測的迫切需求。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業機會分析
    • 產業問題分析
  • 商業環境分析
    • 波特五力分析
    • PESTLE分析

第4章 血流動力學監測設備市場：系統類型估算與趨勢分析

  • 系統類型細分儀表板
  • 系統類型市佔率變化分析，2024 年及 2033 年
  • 按系統類型分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 侵入性
  • 微創
  • 非侵入性

第5章 血流動力學監測設備市場：產品預測與趨勢分析

  • 產品細分儀表板
  • 2024 年及 2033 年產品市佔率變化分析
  • 市場規模、預測與趨勢分析（按產品分類，2021-2033 年）
  • 一次性的
  • 監視器

6. 血流動力學監測設備市場：終端用戶需求預測及趨勢分析

  • 最終用戶細分儀表板
  • 2024 年及 2033 年終端用戶市佔率變化分析
  • 按最終用途分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 醫院
  • 導管檢查室
  • 其他

第7章 血流動力學監測設備市場：區域估算與趨勢分析

  • 區域市場概覽
  • 區域市場：主要結論
  • 北美洲
    • 美國
    • 主要國家的趨勢
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與者概覽
  • 公司市佔率/地位分析，2024 年（%）
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • BD
    • GE HealthCare
    • Baxter
    • ICU Medical, Inc.
    • Koninklijke Philips NV
    • Masimo Corporation
    • Deltex Medical Limited
    • Getinge
    • Nihon Kohden Corporation
    • OSYPKA MEDICAL
    • Schwarzer Cardiotek GmbH
    • Caretaker Medical
    • Medtronic
    • Retia Medical Systems, Inc.
    • Sramek BioDynamics, Inc.
Product Code: 978-1-68038-876-3

Hemodynamic Monitoring Devices Market Summary

The global hemodynamic monitoring devices market size was estimated at USD 1.58 billion in 2024 and is projected to reach USD 2.78 billion by 2033, growing at a CAGR of 6.5% from 2025 to 2033. The growth is driven by several key factors, such as the rising prevalence of cardiovascular diseases and critical illnesses, integration of AI and predictive analytics, growing demand for minimally invasive and non-invasive monitoring techniques, and technological advancements in monitoring devices, including real-time data and wireless connectivity.

The increasing prevalence of CVDs and associated risk factors is anticipated to boost the demand for hemodynamic monitoring devices. Hemodynamic monitoring devices play an increasingly important role in assessing and reducing the risk of heart failure. Hemodynamic monitoring devices, such as implantable devices, provide objective data on factors like pulmonary artery pressure. This allows doctors to identify patients at higher risk for hospitalization or even death from heart failure. Heart failure is one of the leading causes of death across the globe; for instance, according to the CDC, around 6.7 million adults of 20 years and older in the U.S. have heart failure.

In addition, the demand in the hemodynamic monitoring devices industry is constantly growing due to the rising prevalence of Sudden Cardiac Arrests (SCA). Cardiac arrests are generally severe or fatal, and the survival rate in several countries is low, mainly in cases of out-of-hospital attacks. According to the Heart and Stroke Statistics 2022 by the American Heart Association, more than 356,000 out-of-hospital cardiac arrests occur in the U.S. every year, with around 90% of them resulting in death. Hence, the increasing prevalence of cardiac arrest is anticipated to boost the demand for pacemakers.

The aging process significantly changes the cardiovascular system, making careful hemodynamic management essential for older ICU patients. As people age, the balance of the autonomic nervous system gradually shifts: parasympathetic activity weakens while resting sympathetic activity increases. This imbalance heightens the risk of cardiovascular complications in elderly individuals.

At the same time, the global population is aging rapidly. According to the WHO, the number of people aged 60 and above is projected to rise from around 1 billion in 2020 to 1.4 billion by 2030, reaching approximately 2.1 billion by 2050. Consequently, the number of elderly patients experiencing critical illnesses has grown substantially in recent years, underscoring the increasing need for advanced hemodynamic monitoring in this vulnerable population.

Global Hemodynamic Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hemodynamic monitoring devices market report based on system type, product, end use, and region:

  • System Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Invasive
  • Minimally Invasive
  • Non-Invasive
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Disposables
  • Monitors
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Catheterization Labs
  • Other
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. System Type
    • 1.2.2. Product
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of cardiovascular diseases and critical illnesses.
      • 3.2.1.2. Growing demand for minimally invasive and non-invasive monitoring techniques.
      • 3.2.1.3. Technological advancements in monitoring devices, including real-time data and wireless connectivity.
      • 3.2.1.4. Adoption of remote patient monitoring and tele-ICU solutions.
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced hemodynamic monitoring systems
      • 3.2.2.2. Risk of complications with invasive monitoring methods
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Hemodynamic Monitoring Devices Market: System Type Estimates & Trend Analysis

  • 4.1. System Type Segment Dashboard
  • 4.2. System Type Market Share Movement Analysis, 2024 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by System Type, 2021 to 2033 (USD Million)
  • 4.4. Invasive
    • 4.4.1. Market estimates and forecast 2021 to 2033, (USD Million)
  • 4.5. Minimally Invasive
    • 4.5.1. Market estimates and forecast 2021 to 2033, (USD Million)
  • 4.6. Non-Invasive
    • 4.6.1. Market estimates and forecast 2021 to 2033, (USD Million)

Chapter 5. Hemodynamic Monitoring Devices Market: Products Estimates & Trend Analysis

  • 5.1. Products Segment Dashboard
  • 5.2. Products Market Share Movement Analysis, 2024 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Products, 2021 to 2033 (USD Million)
  • 5.4. Disposables
    • 5.4.1. Market estimates and forecast 2021 to 2033, (USD Million)
  • 5.5. Monitors
    • 5.5.1. Market estimates and forecast 2021 to 2033, (USD Million)

Chapter 6. Hemodynamic Monitoring Devices Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. End Use Market Share Movement Analysis, 2024 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast 2021 to 2033, (USD Million)
  • 6.5. Catheterization Labs
    • 6.5.1. Market estimates and forecast 2021 to 2033, (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2021 to 2033, (USD Million)

Chapter 7. Hemodynamic Monitoring Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market: Key Takeaways
  • 7.3. North America
    • 7.3.1. North America Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
    • 7.3.3. Key country dynamics
      • 7.3.3.1. Regulatory framework/Reimbursement Scenario
      • 7.3.3.2. Competitive insights
      • 7.3.3.3. U.S. Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Canada
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework/Reimbursement Scenario
      • 7.3.4.3. Competitive insights
      • 7.3.4.4. Canada Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.5. Mexico
      • 7.3.5.1. Key country dynamics
      • 7.3.5.2. Regulatory framework/Reimbursement Scenario
      • 7.3.5.3. Competitive insights
      • 7.3.5.4. Mexico Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/Reimbursement Scenario
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. Germany Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/Reimbursement Scenario
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. UK Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/Reimbursement Scenario
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. France Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/Reimbursement Scenario
      • 7.4.5.3. Competitive insights
      • 7.4.5.4. Italy Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/Reimbursement Scenario
      • 7.4.6.3. Competitive insights
      • 7.4.6.4. Spain Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/Reimbursement Scenario
      • 7.4.7.3. Competitive insights
      • 7.4.7.4. Denmark Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/Reimbursement Scenario
      • 7.4.8.3. Competitive insights
      • 7.4.8.4. Sweden Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/Reimbursement Scenario
      • 7.4.9.3. Competitive insights
      • 7.4.9.4. Norway Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/Reimbursement Scenario
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Japan Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/Reimbursement Scenario
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. China Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/Reimbursement Scenario
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. India Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/Reimbursement Scenario
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. South Korea Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/Reimbursement Scenario
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Australia Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/Reimbursement Scenario
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Thailand Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Hemodynamic Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/Reimbursement Scenario
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Brazil Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/Reimbursement Scenario
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. Argentina Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/Reimbursement Scenario
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. South Africa Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/Reimbursement Scenario
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Saudi Arabia Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/Reimbursement Scenario
      • 7.7.4.3. Competitive insights
      • 7.7.4.4. UAE Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/Reimbursement Scenario
      • 7.7.5.3. Competitive insights
      • 7.7.5.4. Kuwait Hemodynamic monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Share/Position Analysis, 2024 (%)
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. BD
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. GE HealthCare
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Baxter
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. ICU Medical, Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Koninklijke Philips N.V.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Masimo Corporation
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Deltex Medical Limited
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Getinge
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Nihon Kohden Corporation
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. OSYPKA MEDICAL
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Schwarzer Cardiotek GmbH
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. Caretaker Medical
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Medtronic
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Retia Medical Systems, Inc.
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. Sramek BioDynamics, Inc.
      • 8.5.15.1. Overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product benchmarking
      • 8.5.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Hemodynamic monitoring devicess Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 5 Global Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 6 Global Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Hemodynamic monitoring devicess Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 9 North America Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11 US Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 12 US Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 13 US Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 14 Canada Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 15 Canada Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 16 Canada Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Mexico Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 18 Mexico Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 19 Mexico Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 Europe Hemodynamic monitoring devicess Market, By Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 22 Europe Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 23 Europe Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 24 UK Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 25 UK Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 26 UK Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27 Germany Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 28 Germany Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 29 Germany Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 France Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 31 France Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 32 France Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33 Italy Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 34 Italy Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Italy Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 Spain Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 37 Spain Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 38 Spain Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39 Sweden Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 40 Sweden Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 41 Sweden Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Denmark Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 43 Denmark Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 44 Denmark Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45 Norway Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 46 Norway Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Norway Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Hemodynamic monitoring devicess Market, By Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 52 Japan Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 53 Japan Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 54 Japan Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 55 China Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 56 China Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 57 China Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 India Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 59 India Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 60 India Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 Australia Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 62 Australia Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 63 Australia Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64 South Korea Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 65 South Korea Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 66 South Korea Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Thailand Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 68 Thailand Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 69 Thailand Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 70 Latin America Hemodynamic monitoring devicess Market, By Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 72 Latin America Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 73 Latin America Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74 Brazil Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 75 Brazil Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 76 Brazil Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 77 Argentina Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 78 Argentina Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 79 Argentina Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 80 Middle East and Africa Hemodynamic monitoring devicess Market, By Country, 2021 - 2033 (USD Million)
  • Table 81 Middle East and Africa Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 82 Middle East and Africa Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 83 Middle East and Africa Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 84 South Africa Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 85 South Africa Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 86 South Africa Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 90 UAE Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 91 UAE Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 92 UAE Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Hemodynamic monitoring devicess Market, By System Type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Hemodynamic monitoring devicess Market, By Product, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Hemodynamic monitoring devicess Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Hemodynamic Monitoring Devices market segmentation
  • Fig. 7 Market snapshot
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market driver relevance analysis (current & future impact)
  • Fig. 10 Market restraint relevance analysis (current & future impact)
  • Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Global Hemodynamic Monitoring Devices Market: System Type Outlook Key Takeaways
  • Fig. 14 Global Hemodynamic Monitoring Devices Market: System Type Movement Analysis
  • Fig. 15 Global Invasive Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Global Minimally Invasive Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Global Non-Invasive Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Global Hemodynamic Monitoring Devices Market: Product Outlook Key Takeaways
  • Fig. 19 Global Hemodynamic Monitoring Devices Market: Product Movement Analysis
  • Fig. 20 Global Disposables Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Global Monitors Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Global Hemodynamic Monitoring Devices Market: End Use Outlook Key Takeaways
  • Fig. 23 Global Hemodynamic Monitoring Devices Market: End Use Movement Analysis
  • Fig. 24 Global Hospitals Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Global Catheterization Labs Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Global Others Market Estimates and Forecast Market, 2021 - 2033 (USD Million)
  • Fig. 27 Regional Marketplace: Key Takeaways
  • Fig. 28 Regional outlook, 2024 & 2033
  • Fig. 29 Global Hemodynamic Monitoring Devices Market: Region Movement Analysis
  • Fig. 30 North America Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 31 US Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 32 Canada Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 33 Europe Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 34 Germany Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 35 UK Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 36 France Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 37 Italy Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 38 Spain Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 39 Denmark Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 40 Sweden Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 41 Norway Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 42 Asia pacific Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 43 Japan Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 44 China Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 45 India Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 46 Australia Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 47 South Korea Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 48 Thailand Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 49 Latin America Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 50 Brazil Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 51 Mexico Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 52 Argentina Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 53 Middle East and Africa Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 54 South Africa Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 55 Saudi Arabia Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 56 Kuwait Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)
  • Fig. 57 UAE Hemodynamic Monitoring Devices Market, 2021 - 2033 (USD Million)